Related Experiment Video
Updated: Jan 31, 2026

08:28
Author Spotlight: Advancing Metabolomics Analysis of Rare Hematopoietic Stem Cells
Published on: February 23, 2024
2.5K
Rare T-Cell Subtypes
C van der Weyden1, C McCormack2,3,4, S Lade4,5
1Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, Australia. carrie.vanderweyden@petermac.org.
Cancer Treatment and Research
|January 1, 2019
Summary
This chapter details rare T-cell lymphoma subtypes, refining diagnoses with new techniques. It summarizes current treatment approaches and management controversies for these uncommon conditions.
Area of Science:
- Hematology
- Oncology
- Dermatology
Background:
- Rare T-cell lymphomas present diagnostic challenges in clinical practice.
- Advances in immunohistochemistry and molecular profiling are refining diagnostic categories.
- Several distinct T-cell lymphoma subtypes require better elucidation.
Purpose of the Study:
- To cover diagnostic and clinical features of common rare T-cell lymphoma subtypes.
- To provide a summation of current thinking on optimal treatment approaches.
- To highlight controversies in the management of these rare conditions.
Main Methods:
- Review of diagnostic and clinical features.
- Synthesis of current treatment strategies.
- Identification of management controversies.
Main Results:
- Refined diagnostic categories for rare T-cell lymphomas.
- Detailed descriptions of subcutaneous panniculitis-like T-cell lymphoma, cutaneous gamma-delta T-cell lymphoma, enteropathy-associated T-cell lymphoma, monomorphic epitheliotropic intestinal T-cell lymphoma, primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma, CD4-positive small/medium T-cell lymphoproliferative disorder, and acral CD8-positive T-cell lymphoma.
- Summary of current treatment considerations and controversies.
Conclusions:
- Improved diagnostic techniques aid in classifying rare T-cell lymphomas.
- Optimal treatment strategies are evolving due to limited clinical trial data.
- Further research is needed to establish evidence-based management guidelines for these rare conditions.
Keywords:
Acral CD8-positive T-cell lymphomaCD4-positive small/medium T-cell lymphoproliferative disorderCutaneous gamma-delta T-cell lymphomaEnteropathy-associated T-cell lymphomaMonomorphic epitheliotropic intestinal T-cell lymphomaPrimary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphomaPrimary cutaneous T-cell lymphomaSubcutaneous panniculitis-like T-cell lymphomaRelated Concept Videos
Adrenergic Receptors: ɑ Subtype
2.9K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
2.9K
Adrenergic Receptors: β Subtype
3.8K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
3.8K
Diabetes Mellitus: Overview and Type I Subtype
5.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.3K
What are Cells?
199.3K
Cells are the smallest and basic units of life, whether it is a single cell that forms the entire organism, e.g., in a bacterium or trillions of them, e.g., in humans. No matter what organism a cell is a part of, they share specific characteristics.
Basic Characteristics of Cells
A living cell has a plasma membrane, a bilayer of lipids that separates the aqueous solution inside the cell called the cytoplasm from the outside environment.
Furthermore, a living cell possesses genetic information...
Basic Characteristics of Cells
A living cell has a plasma membrane, a bilayer of lipids that separates the aqueous solution inside the cell called the cytoplasm from the outside environment.
Furthermore, a living cell possesses genetic information...
199.3K
What is Cell Signaling?
130.4K
Despite the protective membrane that separates a cell from the environment, cells need the ability to detect and respond to environmental changes. Additionally, cells often need to communicate with one another. Unicellular and multicellular organisms use a variety of cell signaling mechanisms to communicate to respond to the environment.
130.4K
Concentration Cells
25.9K
A concentration cell is a type of a voltaic cell constructed by connecting two almost identical half-cells, both based on the same half-reaction and using the same electrode, differing only in the concentration of one redox species. A concentration cell's potential, therefore, is determined only by the concentration difference of the particular redox species.
Consider the following voltaic cell:
Consider the following voltaic cell:
25.9K

